CRISPR-based gene disruption coupled to targeted integration of novel, high-avidity, natural T cell receptors to WT1 for acute leukemia
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166507
下载链接
链接失效反馈官方服务:
资源简介:
To better characterize and identify the candidate TCR among the receptors that we have isolated, we dissected the gene expression profiles and biological pathways of HD1- and HD3-TCR edited T cells by single cell sequencing. When challenged with target cells (either WT137-45- pulsed T2 cell line or primary AML blasts), results highlighted an immune response gene signature in each stimulated T cell culture, compared to resting counterparts. Interestingly, upregulation of genes mediating IFNa and g response, T cell proliferation and CD4+ T cell activation was observed in HD1- but not in HD3-TCR T cells stimulated with primary leukemic blasts. T cells harvested from 3 independent donors (DN1, DN2, DN3) were genetically engineered with the TCR gene editing protocol and transduced with the HD1- or HD3-TCR. 14 days upon stimulation with the anti-CD3 and anti-CD28 magnetic beads (ClinExVivo CD3/CD28; Invitrogen), engineered T cells from each donor were co-cultured with WT137-45- pulsed HLA-A*02:01+ T2 cells or with primary leukemic blasts (pAML1) at an effector to target ratio of 2:1. As control we included in the experimental setting HD1- and HD3-edited T cells without further addition of target cells. 24 hours later T cells were enriched by magnetically sorting using the PE-fluorescently labeled Vb8 (for HD1-TCR cultures) and the Vb7.2 (for the HD3-TCR cultures) antibodies and the anti-PE microbeads (Miltenyi Biotec). In total, we collected T cells from 18 different conditions, 6 for each DN included in the analysis: HD1-TCR T cells and HD3-TCR T cells, each left unstimulated, co-cultured with WT137-45-pulsed T2 cells, or co-cultured with pAML1 blasts. Cell hashing (74,75) with anti-human CD45, anti-human CD3 and anti-human β2-microglobulin barcoded antibodies (TotalSeq-C, Biolegend) was performed in order to multiplex samples from each donor in an individual single cell reaction following the manufacturer’s instruction. Afterwards, 5x104 cells/sample were washed and pooled in 3 different Eppendorfs (1 for each donor) in PBS supplemented with 0.04% Bovine Serum Albumine (BSA).
创建时间:
2024-04-13



